Healthcare Innovation November 20, 2024
Despite success in reducing payments, these practices did not reduce the probability of costly inpatient admissions or ED visits, nor did they improve access to timely hospice care
Oncology practices that participated in two-sided risk in the latter half of the Oncology Care Model (OCM) were the main driver of payment reductions in the model, according to an evaluation prepared for the Center for Medicare & Medicaid Innovation.
In February 2015, the Centers for Medicare & Medicaid Services (CMS) invited oncology physician group practices to participate in the OCM, an alternative payment model based on six-month episodes for cancer care for Medicare fee-for-service (FFS) beneficiaries undergoing chemotherapy treatment. The six-year OCM began with six-month chemotherapy treatment episodes, starting on July...
Today's Sponsors
Today's Sponsor